FDA Inspection 1086932 — Creative Testing Solutions

Creative Testing Solutions — FEI 3000204058

The FDA completed an inspection of Creative Testing Solutions on March 21, 2019 in Tempe, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 21, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tempe, AZ (United States)